70 reports of this reaction
3.2% of all DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE reports
#1 most reported adverse reaction
PAIN is the #1 most commonly reported adverse reaction for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, manufactured by Major Pharmaceuticals. There are 70 FDA adverse event reports linking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE to PAIN. This represents approximately 3.2% of all 2,218 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 70 FDA reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.2% of all adverse event reports for DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, making it one of the most commonly reported side effect.
If you experience pain while taking DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.